The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
| Revenue (Most Recent Fiscal Year) | $3.90B |
| Net Income (Most Recent Fiscal Year) | $392.30M |
| PE Ratio (Current Year Earnings Estimate) | 17.48 |
| PE Ratio (Trailing 12 Months) | 18.28 |
| PEG Ratio (Long Term Growth Estimate) | 1.73 |
| Price to Sales Ratio (Trailing 12 Months) | 3.56 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.71 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 12.69 |
| Pre-Tax Margin (Trailing 12 Months) | 15.80% |
| Net Margin (Trailing 12 Months) | 10.39% |
| Return on Equity (Trailing 12 Months) | 9.60% |
| Return on Assets (Trailing 12 Months) | 6.35% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.10 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.23 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.30 |
| Inventory Turnover (Trailing 12 Months) | 1.58 |
| Book Value per Share (Most Recent Fiscal Quarter) | $41.44 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.96 |
| Earnings per Share (Most Recent Fiscal Year) | $3.69 |
| Diluted Earnings per Share (Trailing 12 Months) | $2.06 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 199.98M |
| Free Float | 196.02M |
| Market Capitalization | $14.18B |
| Average Volume (Last 20 Days) | 3.44M |
| Beta (Past 60 Months) | 0.98 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.98% |
| Percentage Held By Institutions (Latest 13F Reports) | 24.39% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |